Steven Leighton
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Highest-materiality recent filing
Axiom Intelligence SPAC signs $15M termination-fee deal to combine with Terra Quantum AG
Up to 75M earnout shares in three tranches at $12.50, $15.00, $17.50 VWAP thresholds over 8 years.
Axiom Intelligence Acquisition Corp 1 announces $3.5B definitive merger with Terra Quantum AG
Equity value of ~$3.5B; pro forma enterprise value of ~$3.6B (no redemptions).
Axiom Intelligence Acquisition Corp 1 closes IPO of 20M units at $10/unit, raising $200M gross
IPO of 20,000,000 units at $10.00/unit closed June 20, 2025, including 2.5M partial over-allotment exercise.
Axiom Intelligence Acquisition Corp 1 completes $200M IPO for European infra SPAC
Closed 20M units at $10/unit, gross proceeds $200M; over-allotment partially exercised for 2.5M units.
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On June 17, 2025, in connection with the IPO, Dr. Claire Handby, Steven Leighton and Christopher Ellis (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
Max materiality 1.00 · Median 0.60 · Most common event m_and_a